Thomas E. Smithgall
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 43
- Protein Structure and Dynamics 17
- Virology 45
- HIV Research and Treatment 45
- Co-authors
- John R. Engen (32 shared papers)T.M. Penning (10 shared papers)Scott Briggs (9 shared papers)Edwina C. Lerner (12 shared papers)Lori A. Emert‐Sedlak (22 shared papers)Matthew B. Wilson (5 shared papers)Jerrod A. Poe (8 shared papers)Anthony P. Schiavone (6 shared papers)
- Journals
- Journal of Biological Chemistry (40 papers)Biochemistry (16 papers)Journal of Molecular Biology (10 papers)PLoS ONE (8 papers)Oncogene (5 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Thomas E. Smithgall
173 papers receiving 7.9k citations
Peers
Comparison fields: 5 of 126
- Virology 1.1k
- Hematology 1.1k
- Oncology 1.8k
- Immunology 1.4k
- Genetics 641
Countries citing papers authored by Thomas E. Smithgall
This map shows the geographic impact of Thomas E. Smithgall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Smithgall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Smithgall more than expected).
Fields of papers citing papers by Thomas E. Smithgall
This network shows the impact of papers produced by Thomas E. Smithgall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Smithgall. The network helps show where Thomas E. Smithgall may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Smithgall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. | 1997 | 339 |
| 2 | 2011 | 227 | |
| 3 | 2009 | 219 | |
| 4 | 1996 | 217 | |
| 5 | 1997 | 188 | |
| 6 | 2013 | 164 | |
| 7 | 2003 | 152 | |
| 8 | 2002 | 150 | |
| 9 | 2008 | 149 | |
| 10 | 2000 | 147 | |
| 11 | 2004 | 141 | |
| 12 | 1996 | 134 | |
| 13 | 2006 | 129 | |
| 14 | 2006 | 124 | |
| 15 | 1986 | 122 | |
| 16 | 2000 | 119 | |
| 17 | 2015 | 118 | |
| 18 | 2001 | 114 | |
| 19 | 2002 | 113 | |
| 20 | 1988 | 107 |
About Thomas E. Smithgall
Thomas E. Smithgall is a scholar working on Molecular Biology, Virology, Hematology, Oncology and Infectious Diseases, having authored 177 papers that have together received 8.0k indexed citations. Recurring topics across this work include HIV Research and Treatment (45 papers), Protein Kinase Regulation and GTPase Signaling (43 papers), HIV/AIDS drug development and treatment (32 papers), Chronic Myeloid Leukemia Treatments (30 papers), Cytokine Signaling Pathways and Interactions (20 papers), Protein Structure and Dynamics (17 papers), Enzyme Structure and Function (16 papers) and Chronic Lymphocytic Leukemia Research (16 papers). The work is most often cited by research in Virology (1.1k citations), Hematology (1.1k citations), Oncology (1.8k citations), Immunology (1.4k citations) and Genetics (641 citations). Thomas E. Smithgall has collaborated with scholars based in United States, Japan and China. Frequent co-authors include John R. Engen, T.M. Penning, Scott Briggs, Edwina C. Lerner, Lori A. Emert‐Sedlak, Matthew B. Wilson, Jerrod A. Poe, Anthony P. Schiavone, Richard Jove and Ronald G. Harvey. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, Journal of Molecular Biology, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.